RA Capital Management Executes $75 Million Stake Acquisition in Artiva Biotherapeutics
In a significant move within the biotechnology sector, RA Capital Management, L.P., alongside several affiliated entities, has completed a substantial acquisition of common stock in Artiva Biotherapeutics, Inc. (NASDAQ: ARTV). The transaction, which occurred on May 11, 2026, involved the purchase of 6,510,416 shares at a price point of $11.52 per s…